论文部分内容阅读
急性淋巴性白血病(ALL)约占成人白血病的20%。小儿ALL的完全缓解率(CR)在90%以上,长期生存率达50～70%,与此相对,成人长期生存率最好也只有35～40%。目前学者们都在苦心研究减少ALL的复发率,廷长缓解期的方法。本文就成人ALL的治疗做以论述。一、预后因素目前已明确,影响ALL预后有几种因素。据报告,这些因素略有不同,可能与治疗效果、观察例数和统计学方法等有关。
Acute lymphoblastic leukemia (ALL) accounts for about 20% of adult leukemias. In children, the complete remission rate (CR) of ALL is above 90% and the long-term survival rate is 50-70%. In contrast, adult long-term survival rate is only 35-40%. At present, scholars are painstaking research to reduce the recurrence rate of ALL, Ting long remission method. This article discusses the treatment of adult ALL to do. First, the prognostic factors have been clear, there are several factors that affect the prognosis of ALL. It is reported that these factors are slightly different and may be related to the therapeutic effect, the observed number of cases and the statistical methods.